Distributing opioid overdose reversal medications (2SSB 5195)

2SSB 5195 helps to increase access to naloxone for all individuals at risk of an opioid overdose. The law requires hospital emergency departments (EDs) and many certified and licensed behavioral health settings to distribute prepackaged naloxone to individuals at risk of an opioid overdose.

Education materials

Please reference appendices J & K in the toolkits to locate translated versions of these educational materials.

Toolkits

Emergency department (ED)

ED toolkit

SB 5195 Emergency Department implementation toolkit

ED appendices

Appendix A. SB 5195 ED requirement summary
Appendix B. Sample naloxone distribution policy
Appendix C. Sample workflow quick sheet
Appendix D. Sample smart phrases
Appendix E. Sample staff training presentation
Appendix F. Sample staff competency
Appendix G. Sample distribution signature sheet
Appendix H. Administrative FAQ
Appendix I. Clinical staff FAQ
Appendix J. Opioid overdose prevention and directions for Naloxone use (trifold brochure) (Includes alternate languages)
Appendix K. Harm reduction strategies and MOUD (trifold brochure) (Includes alternate languages)
Appendix L. Opioid overdose prevention and directions for Naloxone use (flat sheet)
Appendix M. Harm reduction strategies and MOUD (flat sheet)

Behavioral health agency (BHA)

BHA Toolkit

SB 5195 Behavioral Health Agency implementation toolkit

BHA appendices

Appendix A. SB 5195 BHA requirement quick sheet
Appendix B. Administrative FAQ
Appendix C. Frontline staff FAQ
Appendix D. Sample workflow
Appendix E. Sample smart phrases
Appendix F. Sample staff training presentation
Appendix G. Sample staff competency sheet
Appendix H. Sample distribution signature sheet
Appendix I. Opioid overdose prevention and directions for Naloxone use (trifold brochure) (Includes alternate languages)
Appendix J. Harm reduction strategies and MOUD (trifold brochure) (Includes alternate languages)
Appendix K. Opioid overdose prevention and directions for Naloxone use (flat sheet)
Appendix L. Harm reduction strategies and MOUD (flat sheet)

Webinars

HCA Lunch and Learn series for behavioral health agencies (December 8)
- Watch the webinar
- View the slide deck
HCA Lunch and Learn series for behavioral health agencies (December 15)
- Watch the webinar
- View the slide deck

Billing resources

For providers: Provider reimbursement form for opioid reversal medications
Uninsured patients: How to bill for opioid reversal medications FAQ for providers
Opioid reversal medication reimbursement for uninsured clients presentation (April)

Contact

For Medicaid billing and pharmacy questions
Email: Applehealthpharmacypolicy@hca.wa.gov

For assistance on billing for opioid reversal medication for uninsured clients
Email: HCANaloxoneReimbursement@hca.wa.gov

For training, consultation, educational materials, and implementation questions
Laura Meader, MA, LICSW
Overdose reversal medication program director
Email: laura.meader@hca.wa.gov